GlassScriptPhysician profile
Jori L Shaffer
NPI 1205828837
$1,550.89
in general payments reported to CMS, 2019-2025
24 companies · $237 in 2025
The $237 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $172 · 2021: $182 · 2022: $217 · 2023: $235 · 2024: $319 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $652.35 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $208.59 | 2022-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Lilly USA, LLC | $77.80 | 2024-2025 | Jardiance |
| Gilead Sciences, INC. | $57.96 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $56.24 | 2019-2024 | Xarelto |
| Eisai INC. | $48.00 | 2020-2021 | |
| Amgen INC. | $47.75 | 2019-2024 | Otezla, Repatha |
| Grifols USA, LLC | $42.61 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $41.89 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.03 | 2024 | |
| Amarin Pharma, INC. | $32.78 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.77 | 2023 | |
| Sanofi Pasteur INC. | $27.57 | 2019-2022 | |
| Abbott Laboratories | $24.06 | 2025 | Freestyle Libre 3 |
| Alkermes, INC. | $21.13 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $20.66 | 2022 | |
| Corcept Therapeutics | $17.47 | 2023 | Korlym |
| Paratek Pharmaceuticals, INC. | $16.75 | 2024 | Nuzyra |
| Sanofi-Aventis U.S. LLC | $16.72 | 2020 | |
| Genentech USA, INC. | $16.30 | 2020 | |
| Glaxosmithkline, LLC. | $15.36 | 2021 | |
| Phathom Pharmaceuticals, INC. | $14.76 | 2025 | Voquezna |
| Ironshore Pharmaceuticals INC. | $14.27 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jori Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.